Navigation Links
Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016
Date:2/25/2008

Entry of Novel Therapies Including Rituxan/MabThera and Increased Uptake of CellCept Will Provide Effective Treatment Options, According to a New

Report from Decision Resources

WALTHAM, Mass., Feb. 25 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the entry and uptake of high-priced branded agents will drive the systemic lupus erythematosus drug market to quadruple from approximately $325 million in 2006 to $1.4 billion in 2016.

The new Pharmacor report entitled Systemic Lupus Erythematosus finds that the strongest drivers of market growth will be the formal approval of several therapies that target B cells, including Biogen Idec/Genentech/Zenyaku Kogyo's Rituxan/Roche's MabThera, as well as increased uptake of Roche/Aspreva Pharmaceuticals' branded immunosuppressant CellCept.

"The introduction of novel biologics, other targeted therapies, and immunosuppressants into the treatment regimens of patients with systemic lupus erythematosus will result in increased polypharmacy," said Amy Whiting, Ph.D., analyst at Decision Resources. "These agents will not replace existing therapies but rather be used in combination with existing drugs to provide more-effective and/or safer treatment."

The report finds that sales in the systemic lupus erythematosus drug market will experience a significant 24% annual increase between 2006 and 2011. Sales growth will then proceed at a slower pace of 9% annually from 2011 to 2016, owing to fewer new product launches, generic erosion of CellCept, and biogeneric erosion of Rituxan/MabThera.

About Systemic Lupus Erythematosus

Systemic lupus erythematosus is an autoimmune disease characterized by a complex pathophysiology that results in widespread tissue damage of multiple organ systems. The disease affects more than 537,000 people in the United States, France, Germany, Italy
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
2. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
3. The Branded Pharmaceutical Association Comments on Hydrocodone
4. FTCR: Gov. Schwarzenegger Must Follow Through on Call to Ban Blue Cross From Using Doctors as Double-Agents to Dump Sick Patients
5. ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas
6. LiquidAgents Healthcare, LLC Awarded Accreditation from the Joint Commission
7. Insurance Agents Call for State Senate to Improve Californias Health Care Reform Compromise
8. Allergic reactions to gadolinium-based contrast agents are rare, study finds
9. Germ-Fighting Inhaler Could Fend Off Bioterror Agents
10. National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs)
11. Benepath Launches Exclusive Marketing Service for Health Insurance Agents and Agencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Minnesota (PRWEB) , ... September 01, 2015 , ... ... health care delivery options, Blue Cross and Blue Shield of Minnesota (Blue Cross) ... in 2016. , Based in San Francisco, Doctor On Demand provides immediate ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Vendor “Hair Extension Vending Machine,” is still strongly maintaining her firm’s success in ... and beauty tools. In her upcoming city-to-city tour, Ellis will be providing “Look ...
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... Professional Background Screeners (NAPBS®) has announced that Edge Information Management has ... by the Background Screening Credentialing Council (BSCC). , “Achieving and maintaining ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its ... disciplines since its inception more than 35 years ago. A pilot program begun by ... teachers - and, not just those intent on pursuing careers in these fields. The ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Royal River ... new study that followed men and women for 19 years and found that, among ... did not take multivitamins. , The report is part of the September 2015 issue ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... Board Members, Appoints New CEO -, BALTIMORE, ... improving the healthcare of chronically ill seniors, today,announced ... directors to the company,s nine-person board. The modified ... chief executive officer and,chairman of the board., ...
... WINSTON-SALEM, N.C., Jan. 28 DrScore.com, an online,service that lets ... first annual Report Card on Patient Satisfaction in the,U.S., ... company,s,Web site. A few highlights from the report are as ... doctors and their practices across the ...
... microRNAs short strands of RNA that can interfere ... becomes how closely they are associated with cancer. In ... their colleagues have identified two microRNAs (miRNAs) that promote ... may provide an early warning of metastatic breast cancer ...
... Alt receives $1,000 grant for Suicide Awareness Voices ... Alt, a retired,employee with Cargill, earned the company,s ... his work as a volunteer with Suicide,Awareness Voices ... in,Minnesota. Each year the Cargill Cares Volunteer Awards ...
... known if findings apply to humans , , MONDAY, Jan. 28 ... allergic asthma, a new study found. , The mice that ... allergen "inherited" the allergen and developed tolerance to it. , ... animal study can be extrapolated to humans. , "You ...
... PROVIDENCE, R.I. Kids who have been arrested and are ... engage in unsafe sexual activity that puts them at greater ... Hasbro Childrens Research Center. , Findings of the study, published ... Alcohol and Drugs, suggest the need for depression screenings as ...
Cached Medicine News:Health News:XLHealth Corporation Announces Executive Changes 2Health News:DrScore.com Releases Annual Report Card on Patient Satisfaction in the U.S. 2Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3Health News:Volunteer for National Suicide Prevention Agency Earns Cargill Award 2Health News:Breast-Feeding Protected Mice From Asthma 2Health News:Breast-Feeding Protected Mice From Asthma 3Health News:Mental health screenings, risk behavior interventions needed in juvenile justice system 2
(Date:9/1/2015)... Mass. , Sept. 1, 2015  Shareholder rights ... whether certain officers and directors of ConforMIS, Inc. (NASDAQGS: ... ConforMIS is a medical technology company that uses its ... joint replacement implants that are individually sized and shaped ... this press release on the law firm,s Shareholder Rights ...
(Date:9/1/2015)... Australia and Delaware , ... Invion Limited (ASX: IVX; "Company" or "Invion"), is pleased to ... the following securities to an institutional investor in ... aggregate gross proceeds of approximately A$1.001 million ("Placement") by the ... issue price of $0.014 per share. The ...
(Date:9/1/2015)... Israel , Sept. 1, 2015 /PRNewswire/ ... a leading innovator of less invasive, miniaturized circulatory support ... failure, announced today that it has entered into a ... ("Valtech").  Valtech is a privately held company that specializes ... repair and replacement devices for the treatment of the ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10
... , ... ... ... ...
... ... ... , ... , , ...
Cached Medicine Technology:DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 9DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 10DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 11DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 12DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 13DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 14DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 15Hiroshi Uchida Named President and CEO of Magellan 2Hiroshi Uchida Named President and CEO of Magellan 3Hiroshi Uchida Named President and CEO of Magellan 4Hiroshi Uchida Named President and CEO of Magellan 5
... Kit Nebulizer Small Volume Medication Mouthpiece 7FT ... ,These Sidestream® nebulizers are designed ... for any nebulizer treatment with a fast treatment ... with 7` (84") tubing and a vent seal ...
Nebulizer Adapter Kit 6"...
... in Anesthesia and Respiratory Products, ,Westmed ... devices for Anesthesia and Respiratory professionals. Our ... that enhance the clinician's ability to deliver ... to the bottom line. , ,Our ...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
Medicine Products: